| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.59T | 2.43T | 1.83T | 2.21T | 2.00T |
| Gross Profit | 1.17T | 1.15T | 830.27B | 984.41B | 911.82B |
| EBITDA | 748.88B | 759.59B | 508.68B | 660.82B | 636.20B |
| Net Income | 609.10B | 544.13B | 363.96B | 471.58B | 437.08B |
Balance Sheet | |||||
| Total Assets | 2.87T | 2.63T | 2.46T | 2.31T | 1.89T |
| Cash, Cash Equivalents and Short-Term Investments | 508.45B | 496.24B | 472.55B | 473.10B | 371.27B |
| Total Debt | 0.00 | 0.00 | 13.32B | 13.22B | 4.36B |
| Total Liabilities | 794.43B | 770.77B | 696.28B | 712.07B | 547.41B |
| Stockholders Equity | 2.08T | 1.86T | 1.76T | 1.60T | 1.35T |
Cash Flow | |||||
| Free Cash Flow | 350.69B | 414.13B | 309.74B | 349.96B | 218.28B |
| Operating Cash Flow | 572.28B | 582.17B | 434.72B | 426.27B | 283.39B |
| Investing Cash Flow | -102.31B | -169.61B | -125.15B | -41.76B | -55.63B |
| Financing Cash Flow | -451.01B | -388.84B | -325.01B | -256.53B | -167.26B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
84 Outperform | $149.80B | 20.32 | 28.89% | 1.78% | 1.50% | 6.72% | |
84 Outperform | $729.23B | 8.48 | 40.84% | 0.20% | 85.55% | 410.18% | |
81 Outperform | $582.64B | 39.94 | 51.97% | 0.63% | 18.56% | 26.42% | |
81 Outperform | $358.31B | 34.22 | 65.79% | 0.56% | 26.53% | 47.73% | |
77 Outperform | $666.04B | 60.29 | 8.05% | ― | 34.97% | 123.87% | |
72 Outperform | $325.89B | 31.26 | 38.90% | 0.69% | 2.15% | 27.46% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |